Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations
about
Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesisThe UPS: a promising target for breast cancer treatment.2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.Detecting differential allelic expression using high-resolution melting curve analysis: application to the breast cancer susceptibility gene CHEK2.Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer.C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer.Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women.Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.Application of microarray in breast cancer: An overview.Genetic characterization of breast cancer and implications for clinical managementPrevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study.Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer familiesMisbehaviour of XIST RNA in breast cancer cells.MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours.HER2-positive male breast cancer: an update.Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.Pathology of hereditary breast cancer.Triple-negative breast cancer: present challenges and new perspectives.Male breast cancer: genetics, epigenetics, and ethical aspects.Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes.Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.The ubiquitin E3 ligase activity of BRCA1 and its biological functions.Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families.Computational Investigation of Homologous Recombination DNA Repair Deficiency in Sporadic Breast Cancer.Pathology of hereditary breast cancer.Mutational Analysis of Oncogenic AKT1 Gene Associated with Breast Cancer Risk in the High Altitude Ecuadorian Mestizo PopulationClinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy
P2860
Q28274000-D5F6A960-522B-41E6-B274-A4092B1A160DQ33384289-BC99CD57-1031-48F6-AE6E-7F4356625F34Q33848895-595C9717-20EE-4648-B811-01D1D00470B6Q33898712-3C4AAFB4-5166-4CD7-ABA6-6BD5CC07F2E3Q34584767-04B36543-E464-444B-988E-59DA833C74C7Q34769289-F56B2B66-ED3F-4B8B-9DD2-0D9E144E0ABCQ35224593-7EA47053-FC25-47FC-981F-49E41D5BE853Q35565644-25F51A69-0BF3-4E59-8D24-2B3909E3C520Q35647617-FF43E8F8-3316-42DE-8667-8B0CF72074C4Q35770439-0E6128AB-2691-4A2D-AB96-1306EDCF26DEQ35832016-CF37E67B-256E-45D8-A096-A8D471B9A0C2Q36070055-4B191A63-A76A-4798-BD34-036D69E28087Q36643102-E3BBC203-F04F-44A2-87AE-B762D33E5E29Q37184717-4A8265E7-B035-4E2A-B694-E91358D29458Q37322992-52E33DDF-CAD9-4B06-95A2-20048E44BD65Q37355586-B63E106B-23BC-48A0-8C9B-693522AC997EQ37657782-40B91AE3-958E-4B6E-ACCC-BA62AD88D69CQ37740949-250F3BBC-567F-4838-8295-6FEC5B2FC7B4Q37764168-74680063-CCB8-4D1D-B9F4-141DC1B81A62Q38153187-6B738F6A-53F3-4A03-9FCB-DBF0873AE9E6Q38614203-D27BD8EC-960B-453C-92BB-F974458DEE2EQ40258706-58F86AAD-A3AC-4385-8113-5D339D383B01Q42065210-D7059588-B573-4DDB-A292-4B88B632CE4EQ45784223-BCD6767C-EEB4-4CE8-B37B-35B145EA7CF5Q47145727-3D5DCBD4-DE48-4D55-9007-6D5BF88BF4C5Q55110010-5D20B8E1-5E78-4283-A214-C9EBA6BE18F7Q57092342-50992B36-2CC3-4FBA-A512-5590970AB96CQ57419705-411C04C3-508F-4396-9C99-0B7A6026B971
P2860
Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pathology and gene expression ...... BRCA2 and CHEK2 gene mutations
@ast
Pathology and gene expression ...... BRCA2 and CHEK2 gene mutations
@en
Pathology and gene expression ...... BRCA2 and CHEK2 gene mutations
@nl
type
label
Pathology and gene expression ...... BRCA2 and CHEK2 gene mutations
@ast
Pathology and gene expression ...... BRCA2 and CHEK2 gene mutations
@en
Pathology and gene expression ...... BRCA2 and CHEK2 gene mutations
@nl
prefLabel
Pathology and gene expression ...... BRCA2 and CHEK2 gene mutations
@ast
Pathology and gene expression ...... BRCA2 and CHEK2 gene mutations
@en
Pathology and gene expression ...... BRCA2 and CHEK2 gene mutations
@nl
P2860
P50
P356
P1433
P1476
Pathology and gene expression ...... BRCA2 and CHEK2 gene mutations
@en
P2093
J Palacios
P2860
P2888
P304
P356
10.1038/SJ.ONC.1209875
P407
P577
2006-09-25T00:00:00Z
P5875
P6179
1004867215